Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
- 1 January 2016
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 290, 43-53
Abstract
No abstract availableKeywords
Funding Information
- Heilongjiang Province Project of Applied Technology Research and Development (2013GC13C104)
- National Natural Science Foundation of Biological Science (J1210069/J0116)
This publication has 51 references indexed in Scilit:
- Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stressJournal of Gastroenterology, 2012
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathwayBiomaterials, 2011
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and diseaseThe Journal of Biochemistry, 2010
- FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation responseProceedings of the National Academy of Sciences, 2009
- Toll-like receptors as targets in chronic liver diseasesGut, 2009
- Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cellsFibrogenesis & Tissue Repair, 2009
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese MiceDiabetes, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005